期刊文献+

人IFN-λ1重组腺病毒对胃癌细胞增殖的影响及其机制研究 被引量:1

Effects of hIFN-λ1 recombinant adenovirus on proliferation of gastric adenocarcinoma cell line and its mechanism
原文传递
导出
摘要 目的探讨Ad-hIFN-λ1重组腺病毒对胃腺癌细胞SGC-7901增殖的影响及其机制。方法分别用Ad-hIFN-λ1重组腺病毒、Ad-LacZ空质粒及PBS对照组作用于人胃腺癌细胞SGC-7901,MTT法测定细胞增殖情况,RT-PCR检测胃癌SGC-7901中IFN-λ1mRNA的表达,免疫荧光法检测hIFN-λ1蛋白的表达,Tunel、流式细胞术检测细胞凋亡。结果Ad-hIFN-λ1转染胃腺癌细胞SGC-7901后,肿瘤细胞生长明显抑制,细胞中hIFN-λ1 mRNA、蛋白高效表达,细胞凋亡率明显高于Ad-LacZ组、PBS空白对照组。结论Ad-hIFN-λ1重组腺病毒转染至胃腺癌细胞SGC-7901后表达IFN-λ1,Ad-hIFN-λ1能够显著抑制人胃腺癌SGC-7901细胞生长,并可能通过诱导其凋亡而起作用。 Objective To explore the effects of Ad-hIFN-λ1 recombinant adenovirus on prolifera- tion of gastric adenocareinoma cell line SGC-7901 and its mechanism. Methods Ad-hlFN-λ1 recombinant adenovirus and empty plasmid Ad-LacZ were respectively transfated to human gastric adenocarcinoma SGC- 7901 cells. The proliferation of transfected cells was detected by MTT assay. IFN-λ1l gene expression at mR- NA and protein levels in the ceils were measured by RT-PCR analysis and immunofluoreseenee assay, re- spectively. Tunel assay and flow eytometry were used to analyze the rate of cell apoptosis. Results The proliferation of gastric adenoeareinoma SGC-7901 cells were significantly inhibited with Ad-hlFN-λ1 inter- vention in accordance with highly expressed IFN-λ1at mRNA and protein levels, respectively. The apoptosis rate of Ad-hlFN-λ1 transfeeted cells was markedly higher than that of the empty plasmid Ad-LaeZ group and PBS blank control group. Conclusion The expression of hlFN-λ1 could be detected after transfection of Ad-hlFN-λ1 recombinant adenovirus into gastric adenocareinoma SGC-7901 cells. Ad-hlFN-λ1 could signifi- cantly inhibit the proliferation of gastric adenocarcinoma SGC-7901 cells by promoting the apoptosis of cancer cells.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2013年第7期507-512,共6页 Chinese Journal of Microbiology and Immunology
基金 江苏省镇江市2011社发科技支撑项目(SH2011037)
关键词 胃癌 IFN-λ 重组病毒 凋亡 Gastric cancer IFN-λh Recombinant adenovirus Apoptosis
  • 相关文献

参考文献12

  • 1曾绍明.胃癌的诊断与治疗的研究进展[J].右江民族医学院学报,2012,34(4):528-530. 被引量:14
  • 2Ferrantini M, Capone I,Belardelli F. Interferon-alpha and canc-er: mechanisms of action and new perspectives of clinical use.Biochimie, 2007,89(6-7) : 884-893.
  • 3严玉兰,刘洋,曹文雁,步雪峰,步志高,郑金旭.人λ-干扰素在BHK-21中的表达及生物学活性的研究[J].细胞与分子免疫学杂志,2008,24(10):950-953. 被引量:4
  • 4严玉兰,张金,刘洋,袁利学,朱涛峰,郑金旭,步雪峰.鼠IL-28重组腺病毒体外抗肺癌活性研究[J].中华微生物学和免疫学杂志,2011,31(7):638-642. 被引量:1
  • 5Hui X, Chen H, Zhang S, et al. Antitumor activities of recombi-nant human interferon (IFN) -XI in vitro and in xenograft modelsin vivo for colon cancer. Cancer Lett, 2011,311(2) : 141-151.
  • 6Yan Y, Zhang J, Liu Y, et al. Inhibition of lung adenocarcinomatransfected with interleukin 28 A recombinant adenovirus ( Ad-mIFN-X2) in vivo. Cancer Biother Radiopharm, 2013,28(2);124-130.
  • 7严玉兰,袁利学,刘洋,曹文雁,步雪峰,步志高,郑金旭.鼠IFN—λ2 CHO细胞系建立及生物学活性的研究[J].中华微生物学和免疫学杂志,2010,30(2):104-109. 被引量:3
  • 8Meager A, Visvalingam K, Dilger P, et al. Biological activity ofinterleukins-28 and -29 : comparison with type I interferons. Cyto-kine, 2005,31(2) : 109-118.
  • 9Dumoutier L, Tounsi A, Michiels T, et al. Role of the interleukin(IL) -28 receptor tyrosine residues for antiviral and antiproliferativeactivity of IL-29/interferon-lambda 1 : similarities with type I inter-feron signaling. J Biol Chem,2004, 279(31) : 32269-32274.
  • 10Wang 11,Huang 11. Adenovirus technology for gene manipulationand functional studies. Drug Discov Today, 2000, 5(1): 10-16.

二级参考文献58

  • 1王德臣,袁炯,宋世兵,张同琳.48例胃癌根治术的临床体会[J].中国普通外科杂志,2006,15(2):147-149. 被引量:16
  • 2葛来增,吴仕光,龚立鹏,金培勇,李同飞.胃动脉介入化疗栓塞联合根治术治疗进展期胃癌[J].肿瘤防治研究,2007,34(4):300-302. 被引量:13
  • 3Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class Ⅱ cytokine receptor complex. Nat Immunol, 2003,4( 1 ) : 69-77.
  • 4Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class Ⅱ cytokine receptor IL-28R. Nat lmmunol,2003,4( 1 ) : 63- 68.
  • 5Meager A, Visvalingam K, Dilger P, et al. Biological activity of interleukins-28 and-29: comparison with type Ⅰ interferons. Cytokine, 2005, 31(2) : 109-118.
  • 6Dumoutier L, Tounsi A, Michiels T, et al. Role of the interleukin (IL) -28 receptor tyrosine residues for antiviral and antiproliferative activity of IL-29/interferon-lambda 1 : similarities with type Ⅰ interferon signaling. J Biol Chem, 2004, 27 (9) : 32269-32274.
  • 7陈伟业.重组牛、猪和鸡β干扰素在CHO细胞中的高效稳定表达及其生物学活性研究.南京农业大学,2007.
  • 8Meager A. Assays for antiviral activity. Methods Mol Biol, 2004, 249: 121-134.
  • 9Bartlett NW, Buttigieg K, Kotenko SV, et al. Murine interferon lambdas( type Ⅲ interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model. J Gen Virol, 2005, 86 ( Pt 6 ) : 1589-1596.
  • 10Uze G, Monneron D. IL-28 and IL-29 : newcomers to the interferon family. Biochimie, 2007, 89(6-7): 729-734.

共引文献18

同被引文献14

  • 1Sheppard P, Kindsvogel W, Xu W, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R [ J ]. Nat Immunol, 2003, 4(1) : 63-68.
  • 2Kotenko SV, Gallagher G, Baurin VV, et al. IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex[J]. Nat Immunol, 2003, 4(1 ) : 69-77.
  • 3Witte K, Gruetz G, Volk HD, et al. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melano- eytes, have an impaired response to type III interferons: implica- tions for therapeutic applications of these cytokines[J]. Genes Immun, 2009, 10(8) : 702-714.
  • 4Brand S, Beigel F, Olszak T, et al. IL-28A and IL-29 mediate antipmliferative and antiviral signals in intestinal epithelial cells and marine CMV infeetion increases colonic IL-28A expression [J]. Am J Physiol Gastmintest Liver Physiol, 2005, 289 (5) : G960- G968.
  • 5Sato A, Ohtsuki M, Hata M, et al. Antitumor activity of IFN- lambda in murine tumor models [J]. J Immunal, 2006, 176 (12) : 7686-7694.
  • 6Langer JA, Cutrone EC, Kotenko S. The Class II cytokine receptor (CRF2) family: overview and patterns of reeeptor-ligand inter- actions[ J]. Cytokine Growth Factor Rev, 2004, 15 ( 1 ) : 33-48.
  • 7Porta C, Hadj-Slimane R, Nejmeddine M, et al. Interferons alpha and gamma induce p53-dependent and p.53-independent apoptosis, respectively[J]. Oncogene, 2005, 24(4): 605-615.
  • 8Maher SG, Sheikh F, Scarzello A J, et al. IFNalpha and IFNlamb- da differ in their antiproliferative effects and duration of JAK/STAT signaling activity[J]. Cancer Biol Ther, 2008, 7 (7) : 1109- 1115.
  • 9Li Q, Kawamura K, Ma G, et al. Interfemn-lambda induces G1 phase arrest or apoptosis in oesophageal carcinoma cells and pro- duces anti-tumour effects in combination with anti-cancer agents [J]. Eur J Cancer, 2010, 46(1): 180-190.
  • 10Numasaki M, Tagawa M, Iwata F, et al. IL-28 elicits antitumor responses against marine fibrosarcoma[ J]. J Immunol, 2007, 178 (8) : 5086-5098.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部